Literature DB >> 17147632

High-yield production of authentic human growth hormone using a plant virus-based expression system.

Mario Gils1, Romy Kandzia, Sylvestre Marillonnet, Victor Klimyuk, Yuri Gleba.   

Abstract

We describe here a high-yield transient expression system for the production of human growth hormone (hGH, or somatotropin) in transfected Nicotiana benthamiana leaves. The system is based on a recently described plant virus-based modular expression vector [Gleba, Y., Marillonnet, S. and Klimyuk, V. (2004) Engineering viral expression vectors for plants: the 'full virus' and the 'deconstructed virus' strategies. Curr. Opin. Plant Biol. 7, 182-188; Marillonnet, S., Giritch, A., Gils, M., Kandzia, R., Klimyuk, V. and Gleba, Y. (2004) In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium. Proc. Natl. Acad. Sci. USA, 101, 6852-6857], and represents a simple and fast alternative to stable transformation. By using various combinations of provector modules, hGH was produced in three compartments of the cell: the apoplast, the chloroplast and the cytosol. We found that targeting to the apoplast provided the highest amount of correctly processed and biologically active hGH, with a yield of up to 10% of total soluble protein or 1 mg per gram of fresh weight leaf biomass. These results indicate that the use of viral vectors for high-yield production of human therapeutic proteins in plants by transient expression provides an attractive alternative to production protocols using standard expression vectors in transgenic or transplastomic plants.

Entities:  

Year:  2005        PMID: 17147632     DOI: 10.1111/j.1467-7652.2005.00154.x

Source DB:  PubMed          Journal:  Plant Biotechnol J        ISSN: 1467-7644            Impact factor:   9.803


  32 in total

1.  Amplicon-plus targeting technology (APTT) for rapid production of a highly unstable vaccine protein in tobacco plants.

Authors:  Kasi Azhakanandam; Sandra M Weissinger; Jennifer S Nicholson; Rongda Qu; Arthur K Weissinger
Journal:  Plant Mol Biol       Date:  2007-01-14       Impact factor: 4.076

Review 2.  Monoclonal antibody form and function: manufacturing the right antibodies for treating drug abuse.

Authors:  Eric Peterson; S Michael Owens; Ralph L Henry
Journal:  AAPS J       Date:  2006-05-26       Impact factor: 4.009

3.  High-level expression of human interferon alpha-2b in transgenic carrot (Daucus carota L.) plants.

Authors:  Yu Luchakivskaya; O Kishchenko; I Gerasymenko; Z Olevinskaya; Yu Simonenko; M Spivak; M Kuchuk
Journal:  Plant Cell Rep       Date:  2010-11-03       Impact factor: 4.570

4.  High-level expression of Camelid nanobodies in Nicotiana benthamiana.

Authors:  Yi-Hui Audrey Teh; Tony A Kavanagh
Journal:  Transgenic Res       Date:  2009-10-28       Impact factor: 2.788

Review 5.  The effect of the unfolded protein response on the production of recombinant proteins in plants.

Authors:  David Rhys Thomas; Amanda Maree Walmsley
Journal:  Plant Cell Rep       Date:  2014-09-04       Impact factor: 4.570

Review 6.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

7.  Development of Cucumber mosaic virus as a vector modifiable for different host species to produce therapeutic proteins.

Authors:  Kouki Matsuo; Jin-Sung Hong; Noriko Tabayashi; Akira Ito; Chikara Masuta; Takeshi Matsumura
Journal:  Planta       Date:  2006-07-05       Impact factor: 4.116

8.  [Transient expression of bioactive recombinant human plasminogen activator in tobacco leaf].

Authors:  Jiexue Ma; Lele Wu; Xiangzhen Ding; Zhiying Li; Sheng Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-05-30

9.  Improved expression of recombinant plant-made hEGF.

Authors:  David Rhys Thomas; Amanda Maree Walmsley
Journal:  Plant Cell Rep       Date:  2014-07-22       Impact factor: 4.570

10.  Nicotiana benthamiana as a production platform for artemisinin precursors.

Authors:  Teun W J M van Herpen; Katarina Cankar; Marilise Nogueira; Dirk Bosch; Harro J Bouwmeester; Jules Beekwilder
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.